XSNX 0.20 NovAccess Global Inc.
| Range: | 0.0037-0.06 | Vol Avg: | 66429 | Last Div: | 0 | Changes: | 0 |
| Beta: | 1.76 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Mon Sep 21 1998 | Empoloyees: | 3 | ||
| CUSIP: | 67001N107 | CIK: | 0001039466 | ISIN: | US67001N1072 | Country: | US |
| CEO: | Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D. | Website: | https://novaccessglobal.com | ||||
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow